Support program for type 1 diabetes patients using pumps
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a program that gives extra support and follow-up to adults with type 1 diabetes who are already using an insulin pump or closed-loop system and feeling stressed or overwhelmed by their condition. The goal is to see if this support helps reduce diabetes-related distress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have type 1 diabetes
- You have used an insulin pump or closed-loop system for at least 6 months
- You are experiencing moderate to high distress about your diabetes (scoring 6 or higher on a short distress scale)
- You can read and answer questionnaires in French
- You have a valid email address and a cell phone
- You are not currently in another study testing a diabetes device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
This trial tests a program for young adults with type 1 diabetes who feel stressed or overwhelmed by their diabetes. The goal is to see if the program can help reduce diabetes distress and improve well-being.
This trial tests an online support platform to help adults with type 1 diabetes manage their condition. If you live in Canada, have internet access, and can read English or French, you may be able to join.
This trial tests a team-based program that combines diabetes care with mental health support. It aims to help you better manage both your diabetes and emotional well-being through remote check-ins and coaching.
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.